Boston Scientific announces 2025 Investor Day meeting and conference call discussing third quarter 2025 results
Boston Scientific (NYSE: BSX) has announced two upcoming investor events. The company will host its 2025 Investor Day on September 30, 2025, at 8:30 a.m. ET in a hybrid format, where management will discuss financial goals and long-term growth strategies.
Additionally, BSX will hold its Q3 2025 earnings conference call on October 22, 2025, at 8:00 a.m. ET. The call will feature Chairman and CEO Mike Mahoney and CFO Jon Monson. Both events will be webcast live and available for replay on the company's investor relations website.
Boston Scientific (NYSE: BSX) ha annunciato due prossimi eventi per gli investitori. La società terrà il suo Investor Day 2025 il 30 settembre 2025 alle 8:30 ET in formato ibrido, durante il quale il management illustrerà gli obiettivi finanziari e le strategie di crescita a lungo termine.
Inoltre, BSX organizzerà la conference call sui risultati del terzo trimestre 2025 il 22 ottobre 2025 alle 8:00 ET, con la partecipazione del presidente e CEO Mike Mahoney e del CFO Jon Monson. Entrambi gli eventi saranno trasmessi in webcast e disponibili in replica sul sito investor relations della società.
Boston Scientific (NYSE: BSX) ha anunciado dos próximos eventos para inversores. La compañía celebrará su Investor Day 2025 el 30 de septiembre de 2025 a las 8:30 a.m. ET en formato híbrido, donde la dirección expondrá objetivos financieros y estrategias de crecimiento a largo plazo.
Además, BSX realizará su conferencia telefónica de resultados del tercer trimestre de 2025 (Q3 2025) el 22 de octubre de 2025 a las 8:00 a.m. ET, con la participación del presidente y CEO Mike Mahoney y del CFO Jon Monson. Ambos eventos se emitirán en directo por webcast y estarán disponibles en reproducción en la web de relaciones con inversores de la compañía.
Boston Scientific (NYSE: BSX)는 투자자 대상 두 가지 일정을 발표했습니다. 회사는 2025년 9월 30일 오전 8시 30분(동부시간)에 2025 투자자 설명회(Investor Day)를 하이브리드 형식으로 개최하며, 경영진이 재무 목표와 장기 성장 전략을 설명할 예정입니다.
또한 BSX는 2025년 10월 22일 오전 8시(동부시간)에 2025년 3분기 실적 컨퍼런스 콜을 진행합니다. 이번 콜에는 회장 겸 CEO 마이크 매호니(Mike Mahoney)와 CFO 존 몬슨(Jon Monson)이 참여합니다. 두 행사 모두 생중계로 웹캐스트되며, 회사의 투자자 관계 웹사이트에서 다시보기로 제공됩니다.
Boston Scientific (NYSE: BSX) a annoncé deux événements à venir pour les investisseurs. La société organisera son Investor Day 2025 le 30 septembre 2025 à 8h30 ET au format hybride, où la direction présentera les objectifs financiers et les stratégies de croissance à long terme.
Par ailleurs, BSX tiendra sa conférence téléphonique sur les résultats du troisième trimestre 2025 (Q3 2025) le 22 octobre 2025 à 8h00 ET, avec la participation du président-directeur général Mike Mahoney et du directeur financier Jon Monson. Les deux événements seront diffusés en direct en webcast et disponibles en replay sur le site de relations investisseurs de la société.
Boston Scientific (NYSE: BSX) hat zwei bevorstehende Investorenveranstaltungen angekündigt. Das Unternehmen wird seinen Investor Day 2025 am 30. September 2025 um 8:30 Uhr ET im Hybridformat abhalten, bei dem das Management finanzielle Ziele und langfristige Wachstumsstrategien vorstellen wird.
Außerdem wird BSX seine Telefonkonferenz zu den Quartalsergebnissen Q3 2025 am 22. Oktober 2025 um 8:00 Uhr ET abhalten. An der Konferenz werden Vorsitzender und CEO Mike Mahoney sowie CFO Jon Monson teilnehmen. Beide Veranstaltungen werden live per Webcast übertragen und stehen zur Wiederholung auf der Investor-Relations-Website des Unternehmens zur Verfügung.
- None.
- None.
The Investor Day meeting will be held in hybrid format with a simultaneous online webcast. Investors and other interested parties may register for the webcast by visiting the events section on the company's investor website at https://investors.bostonscientific.com. A replay and summary materials from the presentations will also be available online on the website for approximately one year following the event.
Additionally, on Wednesday, October 22, 2025, at 8:00 a.m. ET the company will webcast its conference call discussing financial results and business highlights for the third quarter ending September 30, 2025. The call will be hosted by Mike Mahoney, chairman and chief executive officer, and Jon Monson, executive vice president and chief financial officer. The company will issue a news release announcing financial results for the third quarter on October 22 prior to the conference call.
A live webcast and replay for the event will be accessible at https://investors.bostonscientific.com. The replay will be available approximately one hour following the completion of the event.
About Boston Scientific
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 45 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of healthcare. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. Learn more at www.bostonscientific.com and follow us on LinkedIn.
CONTACTS:
Emily Anderson
Media Relations
+1 (617) 515-2000
Emily.Anderson2@bsci.com
Lauren Tengler
Investor Relations
+1 (508) 683-4479
BSXInvestorRelations@bsci.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/boston-scientific-announces-2025-investor-day-meeting-and-conference-call-discussing-third-quarter-2025-results-302542246.html
SOURCE Boston Scientific Corporation
FAQ
When is Boston Scientific's 2025 Investor Day and how can investors attend?
When will BSX report its Q3 2025 earnings?
Who will present at Boston Scientific's Q3 2025 earnings call?
Where can investors access Boston Scientific's Investor Day and earnings call webcasts?
